Related Experiment Video
Updated: May 19, 2026
05:16
Laparoscopy-endoscopy Cooperative Surgery for the Treatment of Gastric Gastrointestinal Stromal Tumors
Published on: February 19, 2022
Gastrointestinal cancers and the cooperative groups-2011
1Department of Radiation Oncology UNC Lineberger Comprehensive Cancer Center UNC-Chapel Hill School of Medicine Chapel Hill, NC.
Gastrointestinal Cancer Research : GCR
|August 10, 2012
Summary
Extensive changes in U.S. cooperative group structure impact clinical trial systems. Key reforms include new committees and operational restructuring, driven by influential reports.
Area of Science:
- Oncology Clinical Trials
- Health Services Research
Background:
- The U.S. cooperative group structure has undergone significant operational changes in the last 5-10 years.
- These changes have profound implications for the efficiency and effectiveness of clinical trial systems.
Purpose of the Study:
- To discuss recent extensive changes in the U.S. cooperative group structure.
- To analyze the implications of these changes for clinical trial operations.
Main Methods:
- Review of structural changes within U.S. cooperative groups.
- Discussion of key reports influencing operational and structural reforms.
- Analysis of the formation of disease-specific steering committees and task forces.
- Examination of the findings and implementation of the Operational Efficiency Working Group (OEWG).
Main Results:
- Restructuring of cooperative groups has led to new operational paradigms.
- Disease-specific committees enhance focus and efficiency.
- Implementation of OEWG recommendations streamlines trial processes.
Conclusions:
- Recent reforms have significantly reshaped the U.S. cooperative group structure.
- These changes are crucial for the future functioning and advancement of cancer clinical trials.
- Continued adaptation and implementation of evidence-based recommendations are vital.
Related Concept Videos
02:56Treatment Resistent Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
02:56Treatment Resistant Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
01:05Cancer-Critical Genes II: Tumor Suppressor Genes
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
01:05Cancer-Critical Genes II: Tumor Suppressor Genes
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...